You searched for: thyreoideastimulerende (Danska - Engelska)

forhøjet niveau af thyreoideastimulerende hormon i blodet‡**
blood thyroid stimulating hormone increased

forhøjet thyreoideastimulerende hormon i blodet, forhøjet thyroglobulin
blood thyroid stimulating hormone increased, thyroglobulin increased

· overfølsomhed over for bovint eller humant thyreoideastimulerende hormon eller over for et eller
· hypersensitivity to bovine or human thyroid stimulating hormone or to any of the excipients.

iodid optages aktivt i skjoldbruskkirtlen ved en natriumafhængig carrier­medieret transport, som stimuleres af thyreoideastimulerende hormon.
iodide is taken up into the thyroid actively by a sodium-dependent carriermediated pathway which is stimulated by thyroid stimulating hormone.

de biokemiske egenskaber svarer til dem, man finder i naturligt humant thyreoideastimulerende hormon (tsh).
it has comparable biochemical properties to natural human thyroid stimulating hormone (tsh).

nøje overvågning af thyreoideastimulerende hormon (tsh) anbefales derfor hos patienter, der får sevelamercarbonat og levothyroxin.
closer monitoring of thyroid stimulating hormone (tsh) levels is therefore recommended in patients receiving sevelamer carbonate and levothyroxine.

thyrotropin alfa (rekombinant human thyreoideastimulerende hormon) er et heterodimerisk glycoprotein, der produceres ved en rekombinant dna- teknologi.
thyrotropin alfa (recombinant human thyroid stimulating hormone) is a heterodimeric glycoprotein produced by recombinant dna technology.

hos mødre med basedows sygdom kan maternelle tsh (thyreoideastimulerende hormon)-receptor-antistoffer overføres til fostret og medføre forbigående neonatal basedows sygdom.
in mothers with graves’ disease, maternal thyroid stimulating hormone receptor antibodies can be transferred to a developing foetus and can cause transient neonatal graves’ disease.

thyreoidea-funktionsprøver, f.eks. niveauet af thyreoideastimulerende hormon, skal tages før behandlingsstart og hver 3. måned derefter indtil 48 måneder efter sidste infusion.
thyroid function tests, such as thyroid stimulating hormone levels, should be obtained prior to initiation of treatment and every 3 months thereafter until 48 months following the last infusion.

thyreoideastimulerende hormon (tsh) bør monitoreres regelmæssigt, og behandling med thyreoideahormon bør justeres, så der opnås passende tsh-niveauer i henhold til patientens terapeutiske mål.
thyroid stimulating hormone (tsh) levels should be monitored on a regular basis and thyroid hormone administration should be adjusted to reach appropriate tsh levels, according to the patient’s therapeutic target.

hos patienter med thyreoideakræft er der rapporteret adskillige tilfælde af stimuleret tumourvækst i forbindelse med seponering af thyreoideahormoner til diagnostiske procedurer, der er henført til den tilhørende, langvarige forøgelse i mængden af thyreoideastimulerende hormon (tsh).
in patients with thyroid cancer, several cases of stimulated tumour growth have been reported during withdrawal of thyroid hormones for diagnostic procedures which have been attributed to the associated prolonged elevation of thyroid stimulating hormone (tsh) levels.